Skeletal Radiology

, Volume 25, Issue 3, pp 251–254 | Cite as

Cost-effectiveness of ultrasonographic screening for congenital hip dysplasia in new-borns

  • Jonn Terje Geitung
  • Karen Rosendahl
  • Einar Sudmann


Objective. Screening for congenital dysplasia of the hips (CDH) of new-borns, mostly by Ortolani’s or Barlow’s tests, is widely performed, but nevertheless dysplasias are still discovered late. Ultrasonographic screening has been reported to reduce the number of these cases. The present investigation is intended to evaluate the cost-effectiveness of such a screening programme. Materials and methods. The cost of performing ultrasound investigations at Haukeland Hospital and the treatment costs of late-discovered CDH were calculated on the basis of 26 cases of late-discovered CDH at Hagavik Orthopaedic Hospital. Figures for sensitivity and specificity were taken from the literature. Results. General ultrasonographic screening programmes for CDH will not be cost-effective because the population screened will be too large and the demands upon sensitivity too high. However, investigating babies at risk is probably cost-effective. Conclusion. A CDH screening programme requires high sensitivity and one should preferably aim at screening babies at risk. In Norway a centralisation to larger hospitals may therefore be necessary.

Key words Congenital hip dysplasia Ultrasonography Cost-effectiveness Screening programme 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© International Skeletal Society 1996

Authors and Affiliations

  • Jonn Terje Geitung
    • 1
  • Karen Rosendahl
    • 2
  • Einar Sudmann
    • 3
  1. 1.Department of Radiology, Ullevål University Hospital, N-0407 Oslo, NorwayNO
  2. 2.Department of Radiology, Section of Paediatric Radiology, Haukeland University Hospital, N-5021 Bergen, NorwayNO
  3. 3.Hagavik Orthopaedic Hospital, University of Bergen, N-5220 Hagavik, NorwayNO

Personalised recommendations